[1]柯伟,邓小容,李文澜,等.临床-ASPECTS评分不匹配在急性颈内动脉或大脑中动脉主干闭塞8～14 h再通治疗中的探讨[J].卒中与神经疾病杂志,2018,25(05):510-516.[doi:10.3969/j.issn.1007-0478.2018.05.005]
　Ke Wei*,Deng Xiaorong,Li Wenlan,et al.The evaluation of clinical-ASPCTS mismatch in intra-arterial treatment for acute internal carotid artery or middle cerebral artery tunk occlusion within 8-14 hours[J].Stroke and Nervous Diseases,2018,25(05):510-516.[doi:10.3969/j.issn.1007-0478.2018.05.005]
点击复制

临床-ASPECTS评分不匹配在急性颈内动脉或大脑中动脉主干闭塞8～14 h再通治疗中的探讨()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第25卷
期数:
2018年05期
页码:
510-516
栏目:
论 著
出版日期:
2018-10-26

文章信息/Info

Title:
The evaluation of clinical-ASPCTS mismatch in intra-arterial treatment for acute internal carotid artery or middle cerebral artery tunk occlusion within 8-14 hours
文章编号:
1007-0478(2018)05-0510-07
作者:
柯伟; 邓小容; 李文澜; 张兆辉; 杜敏; 杨昊; 刘永明
430060 武汉大学人民医院神经内科(柯伟 张兆辉),麻醉科[李文澜(通信作者)]; 湖北省第三人民医院神经内科[邓小容(通信作者)杜敏 杨昊 刘永明]
Author(s):
Ke Wei*; Deng Xiaorong; Li Wenlan; et al.
*Department of Neurology,Renmin Hospital of Wuhan University,Wuhan 430060
关键词:
临床 Alberta卒中项目早期CT评分 颈内动脉 大脑中动脉 闭塞 脑梗死 脑卒中
Keywords:
Clinical ASPCTS Internal carotid artery Middle cerebral artery Occlusion Brain infarction Strok
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2018.05.005
文献标志码:
A
摘要:
目的 探讨对急性颈内动脉或大脑中动脉主干闭塞8～14 h的患者采用临床-Alberta卒中项目早期CT评分(Alberta stroke programme early CT score,ASPECTS)不匹配指导血管内介入再通治疗的可行性。方法 将2012年1月～2017年12月确诊的41例急性颈内动脉或大脑中动脉主干闭塞的住院患者分为治疗组(24例)和对照组(17例),行ASPECTS评分、改良的脑梗死溶栓(modified Thrombolysis in Cerebral Infarction,mTICI)分级、侧枝代偿评估及症状性颅内出血(symptomatic intracranial hemorrhage,SICH)风险评估; 于入院时和入院治疗后24 h、7d分别进行美国国立卫生研究院卒中量表评分(National Institutes of Health stroke Scale,NIHSS),治疗后90 d用改良Rankin量表(Modified Rankin Scale,mRS)评定临床预后,采用Logistic回归预测良好临床预后的相关因素。结果 与基础NIHSS评分比较,治疗组患者血管再通治疗后24 h和7 d NIHSS评分呈显著性下降(P<0.05),治疗后24 h、7 d NIHSS评分治疗组较对照组显著下降(P<0.05); 治疗后90 d治疗组良好预后较对照组明显改善(P<0.05),治疗组出血转化率较对照组显著下降(P<0.05)。治疗组良好临床预后与临床-ASPECTS不匹配、良好的侧枝代偿等相关。结论 对急性颈内动脉或大脑中动脉主干闭塞8～14 h的患者采用临床-Alberta卒中项目早期CT评分不匹配结合侧枝代偿、mTICI分级可能有利于筛选时间窗外血管再通受益患者。
Abstract:
ObjectiveTo investigate the feasibility of interventional recanalization therapy of clinical-Alberta early in the project CT score(Alberta stroke programme early CT score,ASPCTS)mismatch in acute internal carotid artery or middle cerebral artery tunk occlusion within 8-14 hours.Methods A prospective study was conducted for 24 patients with acute ischemic stroke(AIS)admitted into our hospital with acute internal carotid artery or middle cerebral artery trunk occlusion from January 2012 to May 2015.41 patients were assigned into two groups:the treatment group(n=24)and the control group(n=17).ASPECTS score,Modified Thrombolysis in Cerebral Infarction(mTICI)scales,compensatory collateral and symptomatic intracranial hemorrhage(SICH)risk assessment were evaluated.The scores of National Institutes of Health stroke Scale(NIHSS)were scored at haseline,1,7 d post-admission respectively.Modified Rankin Scale(mRS)were scored were scored at 90th d.The treatment group and the control group were analyzed by Logistic test.Results Compared with baseline NIHSS score,the scores of NIHSS of the treatment group was significantly decreased and was no significant in the control group at 1,7th d(P<0.05).Compared with the control group,the scores of NIHSS of the treatment group was significant at 1,7th d.Compared with the control group,mRS were significant difference at 90 d(P<0.05).Compared with the control group,SICH was significant difference(P<0.05).The correlations for good prognosis in the treatment group were strong with clinical-ASPCTS mismatch,good compensatory collateral.Conclusion To AIS patients with acute internal carotid artery or middle cerebral artery trunk occlusion,clinical-ASPCTS mismatch,compensatory collateral assessment and mTICI classification might facilitate the selection of patients who might benefit from thrombelysis beyond the time window.

参考文献/References:

[1] Kidwell CS,Wintermark M,De Silva DA,et al.Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke[J].Stroke,2013,44(1):73-79.
[2] Lim HS,Lip GY.Thromboprophylaxis in acute ischaemic stroke:how can we PREVAIL?[J].The Lancet Neurology,2007,6(7):578-579.
[3] Wang Y,Liao X,Zhao X,et al.Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China:analysis of the results from the Chinese National Stroke Registry(CNSR)[J].Stroke,2011,42(6):1658-1664.
[4] González RG.Clinical MRI of acute ischemic stroke[J].J Magn Reson Imaging,2012,36(2):259-271.
[5] Fisher M,Albers GW.Advanced imaging to extend the therapeutic time window of acute ischemic stroke[J].Ann Neurol,2013,73(1):4-9.
[6] 孙威,丁则昱,张静波,等.急性脑梗死患者多模式CT指导下的静脉溶栓治疗[J].中华神经科杂志,2010,43(4):256-260.
[7] 王栋; 张新江; 王苇.临床-弥散加权成像不匹配在急性大脑中动脉闭塞患者动脉溶栓中的应用[J].中华神经科杂志,2011,44(12):836-840.
[8] Saňák D,Herzig R,Zapletalová J,et al.Predictors of good clinical outcome in acute stroke patients treated with intravenous thromholysis[J].Acta Neurol Scand,2011,123(5):339-344.
[9] Terasawa Y,Kimura K,Iguchi Y,et al.Could clinical diffusion-mismatch determined using DWI ASPECTS predict neurological improvement after thrombolysis before 3 h after acute stroke?[J].J Neurol Neurosurg Psychiatry,2010,81(8):864-868.
[10] Janjua N,El-Gengaihy A,Pile-Spellman J,et al.Late endovascular revascularization in acute ischemic stroke based on clinical-diffusion mismatch[J].AJNR Am J Neuroradiol,2009,30(5):1024-1027.
[11] 孙士富,何国军,左其龙,等.CT灌注指导下对超时间窗前循环缺血性脑卒中动脉溶栓治疗的有效性及安全性观察[J].中华神经医学杂志,2013,12(11):1096-1100.
[12] Demchuk AM,Hill MD,Barber PA,et al.Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA stroke study[J].Stroke,2005,36(10):2110-2115.
[13] Demchuk AM,Coutts SB.Alberta stroke program early CT score in acute stroke triage[J].Neuroimaging Clin N Am,2005,15(2):409-419,xii.
[14] Aviv RI,Mandelcorn J,Chakraborty S,et al.Alberta stroke program early CT scoring of CT perfusion in early stroke visualization and assessment[J].AJNR Am J Neuroradiol,2007,28(10):1975-1980.
[15] Lin K,Rapalino O,Law M,et al.Accuracy of the Alberta stroke program early CT score during the first 3 hours of middle cerebral artery stroke:comparison of noncontrast CT,CT angiography source images,and CT perfusion[J].AJNR Am J Neuroradiol,2008,29(5):931-936.
[16] Tsivgoulis G,Saqqur M,Sharma VK,et al.Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion[J].J Neuroimaging,2008,18(1):56-61.
[17] 中华神经科学会.中华神经外科学会.各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-381.
[18] Wu O,Schwamm LH,Sorensen AG.Imaging stroke patients with unclear onset times[J].Neuroimaging Clin N Am,2011,21(2):327-344,xi.
[19] Zaidat OO,Yoo AJ,Khatri P,et al.Recommendations on angiographic revascularization grading standards for acute ischemic stroke:a consensus statement[J].Stroke,2013,44(9):2650-2663.
[20] Yoo AJ,Simonsen CZ,Prabhakaran S,et al.Refining angiographic biomarkers of revascularization:improving outcome prediction after intra-arterial therapy[J].Stroke,2013,44(9):2509-2512.
[21] Gur AY,Bornstein NM.TCD and the diamox test for testing vasomotor reactivity:clinical significance[J].Neurol Neurochir Pol,2001,35(Suppl 3):51-56.
[22] Astrup J,Symon L,Branston NM,et al.Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia[J].Stroke,1977,8(1):51-57.
[23] Liu S,Levine SR,Winn HR.Targeting ischemic penumbra Part II:selective drug delivery using liposome technologies[J].J Exp Stroke Transl Med,2011,4(1):16-23.
[24] Asplund K,Glader EL,Norrving B,et al.Effects of extending the time window of thrombolysis to 4.5 hours:observations in the Swedish stroke register(riks-stroke)[J].Stroke,2011,42(9):2492-2497.
[25] Bi M,Ma Q,Zhang S,et al.Local mild hypothermia with thrombolysis for acute ischemic stroke within a 6-h window[J].Clin Neurol Neurosurg,2011,113(9):768-773.
[26] Amenta PS,Ali MS,Dumont AS,et al.Computed tomography perfusion-based selection of patients for endovascular recanalization[J].Neurosurg Focus,2011,30(6):E6.
[27] Deguchi I,Takeda H,Furuya D,et al.Significance of clinical-diffusion mismatch in hyperacute cerebral infarction[J].J Stroke Cerebrovasc Dis,2011,20(1):62-67.
[28] Köhrmann M,Sauer R,Huttner HB,et al.MRI mismatch-based intravenous thrombolysis for isolated cerebellar infarction[J].Stroke,2009,40(5):1897-1899.
[29] Penumbra Pivotal Stroke Trial Investigators.The penumbra pivotal stroke trial:safety and effectiveness of a new Generation of mechanical devices for clotremoval in intracranial large vessel occlusive disease[J].Stroke,2009,40(8):2761-2768.
[30] Zhao Z,Bai Q,Sui H,et al.Fast multimode MRI based emergency assessment of hyperacute stroke thrombolysis[J].Neurol Res,2009,31(4):346-350.
[31] Furlan AJ,Eyding D,Albers GW,et al.Dose escalation of desmoteplase for acute ischemic stroke(DEDAS):evidence of safety and efficacy 3 to 9 hours after stroke onset[J].Stroke,2006,37(5):1227-1231.
[32] Saver JL,Albers GW,Dunn B,et al.Stroke therapy academic industry roundtable(STAIR)recommendations for extended window acute stroke therapy trials[J].Stroke,2009,40(7):2594-2600.
[33] Albers GW,Goldstein LB,Hess DC,et al.Stroke treatment academic industry roundtable(STAIR)recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies[J].Stroke,2011,42(9):2645-2650.
[34] Bourekas EC,Slivka AP,Shah R,et al.Intraarterial thrombolytic therapy within 3 hours of the onset of stroke[J].Neurosurgery,2004,54(1):39-44; discussion 44-6.
[35] Miao Z,Jiang L,Wu H,et al.Randomized controlled trial of symptomatic middle cerebral artery stenosis:endovascular versus medical therapy in a Chinese population[J].Stroke,2012,43(12):3284-3290.
[36] Jiang WJ,Yu W,Du B,et al.Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting[J].Stroke,2011,42(7):1971-1975.
[37] Jauch EC,Saver JL,Adams HP,et al.Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2013,44(3):870-947.
[38] Jahan R.Solitaire flow-restoration device for treatment of acute ischemic stroke:safety and recanalization efficacy study in a swine vessel occlusion model[J].AJNR Am J Neuroradiol,2010,31(10):1938-1943.
[39] Goyal M,Demchuk AM,Menon BK,et al.Randomized assessment of rapid endovascular treatment of ischemic stroke[J].N Engl J Med,2015,372(11):1019-1030.
[40] Campbell BC,Mitchell PJ,Kleinig TJ,et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection[J].N Engl J Med,2015,372(11):1009-1018.
[41] Saver JL,Goyal M,Bonafe A,et al.SolitaireTM with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke(SWIFT PRIME)trial:protocol for a randomized,controlled,multicenter study comparing the Solitaire revascularization device with IV tPA with IV t[J].Int J Stroke,2015,10(3):439-448.
[42] Berkhemer OA,Fransen PS,Beumer D,et al.A randomized trial of intraarterial treatment for acute ischemic stroke[J].N Engl J Med,2015,372(1):11-20.
[43] Albers GW,Marks MP,Kemp S,et al.Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J].N Engl J Med,2018,378(8):708-718.
[44] Nogueira RG,Jadhav AP,Haussen DC,et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J].N Engl J Med,2018,378(1):11-21.
[45] Saver JL,Jahan R,Levy EI,et al.Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke(SWIFT):a randomised,parallel-group,non-inferiority trial[J].Lancet,2012,380(9849):1241-1249.
[46] Pereira V,Gralla J,Davalos A,et al.Prospective,multicenter,single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acuteischemic stroke[J].Stroke,2013,44(10):2802-2807.
[47] Chuang YM,Chan L,Lai YJ,et al.Configuration of the circle of Willis is associated with less symptomatic intracerebral hemorrhage in ischemicstroke patients treated with intravenous thrombolysis[J].J Crit Care,2013,28(2):166-172.
[48] Christoforidis GA,Mohammad Y,Kehagias D,et al.Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis foracute ischemic stroke[J].AJNR Am J Neuroradiol,2005,26(7):1789-1797.
[49] Liebeskind DS,Cotsonis GA,Saver JL,et al.Collaterals dramatically alter stroke risk in intracranial atherosclerosis[J].Ann Neurol,2011,69(6):963-974.
[50] 症状性颅内动脉粥样硬化性狭窄血管内治疗专家共识组.症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识[J].中华内科杂志,2013,52(3):271-275.
[51] Bang OY,Saver JL,Kim SJ,et al.Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke[J].Stroke,2011,42(8):2235-2239.
[52] Christoforidis GA,Karakasis C,Mohammad Y,et al.Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke:the role of pial collateralformation[J].AJNR Am J Neuroradiol,2009,30(1):165-170.

更新日期/Last Update: 2018-10-20